Most recent by Lara Devgan, MD, MPH, FACS
RelabotulinumtoxinA demonstrates rapid, long-lasting results for frown lines
Single dose relabotulinumtoxinA demonstrated rapid onset, long-lasting duration of aesthetic efficacy and high patient satisfaction for the treatment of frown lines, Galderma announced in a press release.
Q&A: Botox Cosmetic’s FDA approval may lead to higher visibility, more patient inquiries
Healio spoke with Darin Messina, PhD, on the significance and practical impact of the FDA’s most recent approval of Botox Cosmetic for platysma bands.
Q&A: Appropriately sized instruments needed for female surgeons
The lack of surgical instruments tailored for women’s hands is just one example of the gender inequity female surgeons face in the workforce.
FDA issues warning for OTC topical pain relievers with high levels of lidocaine
The FDA has warned consumers to avoid certain over-the-counter pain relief topicals that are used before, during or after cosmetic procedures due to potential safety risks, according to a press release.
Q&A: What clinicians should know about viral beauty trend ‘Barbie Botox’
Following the release of the “Barbie” movie in July 2023, a new cosmetic trend called “Barbie Botox” has taken social media by storm.